Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Delayed Hemolytic Transfusion Reaction: Clinical Presentation and Characteristics

Clinical Manifestations

  • A delayed hemolytic transfusion reaction (DHTR) presents as a significant drop in hemoglobin within 21 days post-transfusion, often accompanied by hemoglobinuria, jaundice, fever, bone pain, and symptoms that can mimic a vaso-occlusive crisis in sickle cell disease patients 1
  • Accelerated HbS% increase with concomitant fall in HbA in sickle cell patients post-transfusion 1
  • Significant LDH rise from baseline reflecting red cell destruction 1
  • Relative reticulocytopenia or paradoxical reticulocytosis from baseline values 1

Hyperhemolysis Syndrome

  • The most severe form of DHTR is hyperhemolysis syndrome, where hemoglobin rapidly declines below the pre-transfusion level, indicating destruction of both transfused and the patient's own red blood cells 1